BioCentury | Jul 19, 2018
Politics & Policy

FDA reorganizing commissioner’s office

...Office of Women’s Health, and the Office of Laboratory Safety will be supervised by the Office of the Chief Scientist. Steve...
BioCentury | Jan 4, 2018
Strategy

Next generation resolutions

...perform.” Elaine Johanson, who is acting director of the Office of Health Informatics at FDA’s Office of the Chief Scientist...
BioCentury | Dec 23, 2017
Regulation

Prioritizing preferences

...a strategic decision by FDA’s Office of Regulatory Science and Innovation, which sits within the Office of the Chief Scientist...
BioCentury | Oct 19, 2017
Finance

Broad umbrella

...for a cut of future fund profits FutuRx Accelerator Jan. 2014 The Technological Incubators Program, Office of the Chief Scientist...
BioCentury | May 30, 2016
Finance

Re-upping in Israel

...with the Israeli government, Johnson & Johnson (NYSE:JNJ) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). Israel's Office of the Chief Scientist...
...million in non-dilutive financing to each FutuRx company. "After companies graduate from the incubator, Israel's Office of the Chief Scientist...
BioCentury | Mar 10, 2015
Politics & Policy

FDA appoints Borio acting chief scientist

...policy and director of the FDA's Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist...
BioCentury | Nov 3, 2014
Strategy

Translation in Asia

...pharmaceutical component, including 70% where drug candidates are the sole focus. (A) Public-private partnership with Office of the Chief Scientist...
BioCentury | Jan 30, 2014
Translation in Brief

Translational tidbits

...Scientific Research; The National Centre for Research and Development; National Science Centre; Project Management Julich; Office of the Chief Scientist...
BioCentury | Jan 16, 2014
Strategy

Biotech kibbutz

...Innovation, the pharma's early stage collaborations unit. FutuRx is the result of efforts by Israel's Office of the Chief Scientist...
BioCentury | Jan 13, 2014
Company News

J&J, Takeda other news

...company can remain in the incubator for up to three years. The pharma said Israel's Office of the Chief Scientist...
Items per page:
1 - 10 of 24
BioCentury | Jul 19, 2018
Politics & Policy

FDA reorganizing commissioner’s office

...Office of Women’s Health, and the Office of Laboratory Safety will be supervised by the Office of the Chief Scientist. Steve...
BioCentury | Jan 4, 2018
Strategy

Next generation resolutions

...perform.” Elaine Johanson, who is acting director of the Office of Health Informatics at FDA’s Office of the Chief Scientist...
BioCentury | Dec 23, 2017
Regulation

Prioritizing preferences

...a strategic decision by FDA’s Office of Regulatory Science and Innovation, which sits within the Office of the Chief Scientist...
BioCentury | Oct 19, 2017
Finance

Broad umbrella

...for a cut of future fund profits FutuRx Accelerator Jan. 2014 The Technological Incubators Program, Office of the Chief Scientist...
BioCentury | May 30, 2016
Finance

Re-upping in Israel

...with the Israeli government, Johnson & Johnson (NYSE:JNJ) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). Israel's Office of the Chief Scientist...
...million in non-dilutive financing to each FutuRx company. "After companies graduate from the incubator, Israel's Office of the Chief Scientist...
BioCentury | Mar 10, 2015
Politics & Policy

FDA appoints Borio acting chief scientist

...policy and director of the FDA's Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist...
BioCentury | Nov 3, 2014
Strategy

Translation in Asia

...pharmaceutical component, including 70% where drug candidates are the sole focus. (A) Public-private partnership with Office of the Chief Scientist...
BioCentury | Jan 30, 2014
Translation in Brief

Translational tidbits

...Scientific Research; The National Centre for Research and Development; National Science Centre; Project Management Julich; Office of the Chief Scientist...
BioCentury | Jan 16, 2014
Strategy

Biotech kibbutz

...Innovation, the pharma's early stage collaborations unit. FutuRx is the result of efforts by Israel's Office of the Chief Scientist...
BioCentury | Jan 13, 2014
Company News

J&J, Takeda other news

...company can remain in the incubator for up to three years. The pharma said Israel's Office of the Chief Scientist...
Items per page:
1 - 10 of 24